Inventor · disambiguated record
Hanna Tinel
Also filed as: TINEL HANNA
32 granted patents·20 pending applications·133 citations·filing 2003–2024
96Inventor score
Files withBayer Pharma AG31BAYER AG9BAYER HEALTHCARE AG6BAYER SCHERING PHARMA AG1Bater Healthcare AG1
Top patents by PatentIndex Score
52 records- 0194US10300062B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2018·Granted May 28, 2019·11 cites·21 claims
- 0293US9949978B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2016·Granted Apr 24, 2018·12 cites·42 claims
- 0393US9949977B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2016·Granted Apr 24, 2018·12 cites·19 claims
- 0493US9481672B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2013·Granted Nov 1, 2016·18 cites·44 claims
- 0592US9988367B2Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Jun 5, 2018·5 cites·14 claims
- 0689US8981104B25-aminotetrahydroquinoline-2-carboxylic acids and their useBayer Pharma AG·Filed 2013·Granted Mar 17, 2015·13 cites·12 claims
- 0785US10435403B2Positive allosteric modulators of muscarinic M2 receptorBayer Pharma AG·Filed 2016·Granted Oct 8, 2019·7 cites·8 claims
- 0885US9382305B2Relaxin fusion polypeptides and uses thereofWILMEN ANDREAS·Filed 2012·Granted Jul 5, 2016·20 cites·17 claims
- 0984US10526314B2Hydroxyalkyl-substituted heteroaryltriazole derivatives and uses thereofBAYER AG·Filed 2017·Granted Jan 7, 2020·3 cites·6 claims
- 1084US10472348B2Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Granted Nov 12, 2019·3 cites·12 claims
- 1183US9624199B2Substituted bipiperidinyl derivativesBayer Pharma AG·Filed 2014·Granted Apr 18, 2017·7 cites·19 claims
- 1282US9688636B25-aminotetrahydroquinoline-2-carboxylic acids and their useBayer Pharma AG·Filed 2015·Granted Jun 27, 2017·3 cites·8 claims
- 1379US10053428B25-aminotetrahydroquinoline-2-carboxylic acids and their useBayer Pharma AG·Filed 2017·Granted Aug 21, 2018·2 cites·34 claims
- 1478US9624198B2Substituted piperidinyltetrahydroquinolinesBayer Pharma AG·Filed 2014·Granted Apr 18, 2017·4 cites·20 claims
- 1576US10815205B2Amide-substituted phenyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Oct 27, 2020·2 cites·13 claims
- 1676US9944621B2Substituted piperidinyl tetrahydroquinolinesBayer Pharma AG·Filed 2014·Granted Apr 17, 2018·2 cites·22 claims
- 1775US9695131B2Substituted uracils as chymase inhibitorsBayer Pharma AG·Filed 2014·Granted Jul 4, 2017·2 cites·4 claims
- 1874US10519154B27-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereofBayer Pharma AG·Filed 2017·Granted Dec 31, 2019·2 cites·14 claims
- 1974US9751843B2Substituted uracils and use thereofBayer Pharma AG·Filed 2014·Granted Sep 5, 2017·2 cites·10 claims
- 2072US12138256B2Treatment of cardiopulmonary disordersBAYER AG·Filed 2023·Granted Nov 12, 2024·0 cites·30 claims
- 2172US10927109B27-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereofBAYER AG·Filed 2017·Granted Feb 23, 2021·1 cites·19 claims
- 2270US11091463B2Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2019·Granted Aug 17, 2021·0 cites·9 claims
- 2369US2025090519A1Treatment of cardiopulmonary disordersBAYER AG·Filed 2024·Application pending·0 cites
- 2468US8153160B2Pharmaceutical dosage forms comprising an active ingredient combination of nifedipine and/or nisoldipine and an angiotensin II antagonistOHM ANDREAS·Filed 2006·Granted Apr 10, 2012·2 cites·38 claims
- 2565US2020061063A1Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2019·Application pending·0 cites
- 2664US2019144423A1Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2763US10961221B2Substituted piperidinyl tetrahydroquinolinesBayer Pharma AG·Filed 2017·Granted Mar 30, 2021·0 cites·5 claims
- 2859US11472803B27-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereofBAYER AG·Filed 2021·Granted Oct 18, 2022·0 cites·3 claims
- 2959US10323020B2Substituted piperidinyl tetrahydroquinolinesBayer Pharma AG·Filed 2017·Granted Jun 18, 2019·0 cites·3 claims
- 3059US2025302837A1Inhibitors of chymase for use in the selective resolution of thrombi in thrombotic or thromboembolic disordersSOCPRA SCIENCES SANTE ET HUMAINES S E C·Filed 2023·Application pending·0 cites
- 3159US2010210643A1sGC STIMULATORS, sGC ACTIVATORS AND COMBINATIONS FOR THE TREATMENT OF UROLOGICAL DISORDERSBAYER SCHERING PHARMA AG·Filed 2008·Application pending·0 cites
- 3256US2025281480A1Pharmaceutical dry powder inhalation formulationBAYER AG·Filed 2022·Application pending·0 cites
- 3351US2019367516A1Positive allosteric modulators of muscarinic m2 receptorBayer Pharma AG·Filed 2019·Application pending·0 cites
- 3449US2021253557A1Substituted triazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Application pending·0 cites
- 3549US2012122820A1Prodrugs and the use thereofDIEDRICHS NICOLE·Filed 2008·Application pending·0 cites
- 3648US11149023B2Substituted triazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Granted Oct 19, 2021·0 cites·11 claims
- 3748US2017267648A1Substituted uracils as chymase inhibitorsBayer Pharma AG·Filed 2017·Application pending·0 cites
- 3847US2020230136A1Selective adrenoreceptor alpha2c receptor antagonists alone, or in combination with chymase inhibitors for use in the treatment and/or prophylaxis of peripheral artery diseases (pad)BAYER AG·Filed 2018·Application pending·0 cites
- 3946US11331314B2Amine substituted triazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Granted May 17, 2022·0 cites·11 claims
- 4046US2016287599A1Substituted 1,2,4-triazine-3,5-diones and the use thereof as chymase inhibitorsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4146US2005222247A1Chroman derivativesBAYER HEALTHCARE AG·Filed 2004·Application pending·0 cites
- 4246US2016318866A1Substituted bipiperidinyl derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4344US11298367B2Prodrugs of substituted triazole derivatives and uses thereofBAYER AG·Filed 2018·Granted Apr 12, 2022·0 cites·12 claims
- 4444US11230540B2Substituted triazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Granted Jan 25, 2022·0 cites·13 claims
- 4544US2009176791A1Diaryl Ureas for Treating Pulmonary HypertensionBAYER HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 4644US2009186896A1PDE Inhibitors and Combinations Thereof for the Treatment of Urological DisordersBAYER HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 4743US7498460B2Isophthalic acid derivativesBAYER HEALTHCARE AG·Filed 2003·Granted Mar 3, 2009·0 cites·9 claims
- 4843US2010035888A1Diaryl Urea for Treating Pulmonary HypertensionBater Healthcare AG·Filed 2006·Application pending·0 cites
- 4942US11173151B2Substituted triazole derivatives and uses thereofBAYER AG·Filed 2018·Granted Nov 16, 2021·0 cites·13 claims
- 5041US2008176898A1Phenyl AcetamidesBAYER HEALTHCARE AG·Filed 2005·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hanna Tinel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →